Envoy Medical (NASDAQ:COCH) Earns Buy Rating from Analysts at Brookline Capital Management

Brookline Capital Management started coverage on shares of Envoy Medical (NASDAQ:COCH) in a research note published on Monday, MarketBeat.com reports. The firm issued a buy rating and a $9.00 price objective on the stock. Brookline Capital Management also issued estimates for Envoy Medical’s Q3 2024 earnings at ($0.27) EPS, Q4 2024 earnings at ($0.29) EPS, Q1 2025 earnings at ($0.52) EPS, Q2 2025 earnings at ($0.39) EPS, Q3 2025 earnings at ($0.32) EPS, Q4 2025 earnings at ($0.33) EPS and FY2025 earnings at ($1.56) EPS.

Separately, Ascendiant Capital Markets upped their price objective on Envoy Medical from $8.50 to $8.75 and gave the company a “buy” rating in a research note on Tuesday, September 3rd.

Envoy Medical Stock Up 7.9 %

NASDAQ COCH opened at $2.72 on Monday. The firm’s fifty day moving average price is $3.00 and its two-hundred day moving average price is $3.17. Envoy Medical has a fifty-two week low of $0.75 and a fifty-two week high of $11.46.

Envoy Medical (NASDAQ:COCH) last issued its quarterly earnings data on Monday, August 12th. The company reported ($0.27) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.03). The company had revenue of $0.07 million during the quarter, compared to analyst estimates of $0.08 million. As a group, sell-side analysts expect that Envoy Medical will post -1.22 earnings per share for the current year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Envoy Medical stock. Virtu Financial LLC acquired a new position in shares of Envoy Medical, Inc. (NASDAQ:COCH) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 14,045 shares of the company’s stock, valued at approximately $55,000. Virtu Financial LLC owned about 0.07% of Envoy Medical at the end of the most recent reporting period. Hedge funds and other institutional investors own 8.59% of the company’s stock.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.